Advagene Biopharma Co., Ltd. (6709)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
26. 00
-0.5
-1.8868%
NT$
- Market Cap
- P/E Ratio
- Div Yield
18,001 Volume
- Eps
NT$ 26.5
Previous Close Want to track 6709 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Advagene Biopharma Co., Ltd. (6709) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.72B
Trailing P/E (ttm) -22.52
Forward P/E -
PEG ratio 0.28
Price/Sales (ttm) -
Price/Book (mrq) 10.1
Enterprise Value/Revenue -
Enterprise Value/EBITDA -24.7
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 72.46K
Average volume (90 days) 60.95K
Price summary
52-Week low 21.6
52-Week high 41
Beta -
50-Day moving average 24.66
200-Day moving average 27.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.27
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 13.69%
Book value per share (mrq) 2.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
